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Heterotopic pregnancy is the simultaneous occurrence of two pregnancies at two different implantation sites,
mostly intrauterine and extrauterine sites. An interstitial ectopic pregnancy as part of a heterotopic pregnancy is
very rare. This report highlights the case of a 40-year-old woman with heterotopic pregnancy who had conceived
via assisted reproductive technology. The patient had an interstitial ectopic pregnancy and a viable intrauterine
pregnancy. She was treated expectantly and had cesarean delivery of the intrauterine pregnancy at 38 weeks of
gestation. Although management options for heterotopic pregnancies include surgical and medical, it may be
reasonable to consider expectant management for select cases while weighing risks. In such cases, close moni
toring of symptoms and serial ultrasound examinations should be standard.

1. Introduction
Heterotopic pregnancy is the simultaneous occurrence of two preg
nancies at two different implantation sites, mostly occurring as intra
uterine and extrauterine pregnancies [1]. It occurs in 1 in 30,000
spontaneous pregnancies [2]. The incidence of heterotopic pregnancy
can rise up to 1 in 3000 for women who have used assisted reproductive
technology and had ovulation induction [3]. An interstitial heterotopic
pregnancy is even more rare, representing 2%–4% of all ectopic preg
nancies, but have a much higher mortality rate overall [4].
Patients with heterotopic pregnancies can present with symptoms of
abdominal pain or vaginal bleeding, but in many cases can be asymp
tomatic [5]. Heterotopic pregnancy is commonly diagnosed via trans
vaginal ultrasound [6], and diagnosis is usually delayed because of the
presence of an intrauterine gestational sac [7]. Hemorrhage can be
dramatic if rupture occurs in the interstitial portion of the fallopian tube.
The management of a heterotopic pregnancy includes surgical, medical,
or expectant options [8,9].
Around 500 reported cases of heterotopic pregnancies have been
reported in the literature, the majority of which are tubal heterotopic,
and a few being interstitial heterotopic in nature [10]. These cases vary
in terms of risk factors, symptoms, diagnosis, and management
approach. The current case concerns the rare presentation of a patient

with an interstitial heterotopic pregnancy that was likely the result of
assisted reproductive technology. The patient was expectantly treated
via successful cesarean delivery at 38 weeks of gestation.
2. Case Presentation
A 40-year-old woman, G2P1001, presented to labor and delivery
triage at 6 weeks of gestation because of abnormal ultrasound results.
Ultrasound had shown a viable, intrauterine pregnancy and an anechoic
thick-rim cystic structure at the right lateral fundus within the intersti
tial portion of the fallopian tube with a mild vascular rim with a small
amount of free fluid in the cul de sac [Fig. 1]. She had received artificial
insemination 4 weeks prior after having had clomiphene treatment. Due
to ovulation induction with clomiphene citrate, the patient was at risk
for multiple gestation complications, including heterotopic pregnancy.
Magnetic resonance imaging (MRI) of the pelvis showed a 2.1 × 1.4 cm
cystic structure in the right interstitial region of the uterus, which was
concerning for heterotopic interstitial pregnancy [Fig. 1]. The patient
was otherwise healthy with no major medical issues aside from one prior
cesarean section. She was counseled on the options of surgical man
agement with interstitial ectopic resection/aspiration and expectant
management with close surveillance via weekly ultrasounds. This was a
highly desired pregnancy, and she was asymptomatic. She elected for
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Fig. 1. Ultrasound (left) and MRI (right) showing the intrauterine and interstitial heterotopic pregnancies at 6 weeks of gestation.

Fig. 2. Interstitial heterotopic (left) and intrauterine pregnancy (right) at 12 weeks of gestation.

expectant management with serial ultrasound examination, serial he
moglobin evaluations, and precautions.
She had follow-up serial ultrasounds at 7 weeks, 8 weeks, and 10
weeks of gestation. The final ultrasound showed the intrauterine preg
nancy and a persistent irregular 1.5 × 1.6 × 1.1 cm cystic structure in
the interstitial portion of the right fallopian tube, which had decreased
in size relative to the patient's first ultrasound and which was consistent
with an anembryonic pregnancy at 12 weeks [Fig. 2]. The free fluid in
the cul de sac was noted to be absent on the subsequent ultrasounds. The
cystic structure in the right interstitial region was last visualized on
ultrasound at 17 weeks of gestation and was stable in size. All subse
quent ultrasounds no longer identified the heterotopic pregnancy. The
plan was made for delivery at 38 weeks of gestation via cesarean
delivery.
The patient presented at 38 weeks and 2 days for her scheduled ce
sarean delivery. Intraoperative findings included a 3210 g viable male
neonate in vertex presentation with Apgar scores of 8 at one minute and
9 at five minutes. Thorough evaluation revealed normal uterine outline,
tubes, and ovaries. There was no evidence of heterotopic pregnancy and
no evidence of dilation of the interstitial region or fallopian tubes
bilaterally. Her postpartum course was uncomplicated. She presented
for her 4-week postoperative visit and had no concerns at that time.

3. Discussion
Heterotopic intrauterine and extrauterine pregnancies are suspected
when ultrasound examination shows an intrauterine pregnancy and a
complex adnexal mass or general extrauterine finding. The ultrasound
can be diagnostic when the mass contains a yolk sac or embryo/fetal
pole. Generally, patients with heterotopic pregnancies can be symp
tomatic with abdominal pain or vaginal bleeding, much like symptoms
for an ectopic pregnancy. The patient in this case was asymptomatic,
with ultrasound showing a thick-rim cystic structure with no embryo,
yolk sac, or gestational sac, but the suspicion for a heterotopic preg
nancy was high because of her previous clomiphene intervention during
artificial insemination. Follow-up pelvic MRI demonstrated interstitial
heterotopic pregnancy to be the likely diagnosis, favoring anembryonic
pregnancy.
After the diagnosis of heterotopic pregnancy is made, patients should
promptly undergo discussion of management options to avoid adverse
effects that may be associated with ectopic pregnancy rupture, such as
hemodynamic shock and death. In cases of heterotopic interstitial
pregnancies, the risk of rupture in the interstitial region is as high as
49% [4], and maternal mortality associated with hemorrhage occurs in
2%–3% of these cases [11]. Management options include surgical,
medical, or expectant, and all options should be presented to all patients.
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Laparoscopic salpingectomy is a standard approach for surgical man
agement of tubal heterotopic pregnancies, depending on the location of
the pregnancy, whereas cornual wedge resection is the standard surgical
approach for treating patients with interstitial heterotopic pregnancies.
Because of the anatomical location of interstitial heterotopic pregnan
cies, cornual wedge resections pose increased risk for hemorrhage, blood
loss, and potential for uterine rupture. Surgical management is recom
mended for hemodynamically unstable patients. Surgical management
includes risk of intra-uterine fetal loss, which may impact a patient's
decision-making in a highly desired pregnancy.
Medical management options include local injection of potassium
chloride or methotrexate under ultrasound guidance into the sac fol
lowed by aspiration of the ectopic pregnancy. Intralesional potassium
chloride was not an option for this case because of the absence of cardiac
activity. Intralesional methotrexate was not an option because of the
presence of the intrauterine pregnancy and risk of congenital malfor
mations. Expectant management carries the risks of bleeding, loss of the
intrauterine pregnancy, and maternal death, and this approach may lead
to the need for surgical intervention or hysterectomy. The patient in this
case elected for expectant management. She understood that by delaying
surgical or medical intervention, she was placing herself at risk for
rupture and its associated complications and morbidity/mortality.
Following the decision, close follow-up with serial ultrasounds was
necessary. She was also offered in-patient admission, which she
declined. Repeat serial ultrasounds every 2 weeks were reassuring,
showing gradual decrease in the size of the adnexal cystic mass and,
ultimately, the absence of free pelvic fluid. The cystic structure was last
visualized on ultrasound at 17 weeks of gestation and was never sub
sequently observed on ultrasound. Ultimately, when the patient un
derwent the cesarean delivery at 38 weeks of gestation, there was no
evidence of heterotopic pregnancy and no evidence of dilation of the
interstitial region or fallopian tubes bilaterally.
In conclusion, although this case highlights a patient who was
asymptomatic, physicians should always consider heterotopic preg
nancy in the differential diagnosis when a heterotopic mass is observed
on ultrasound, particularly for patients with risk factors. Once diag
nostic imaging raises the suspicion for a heterotopic pregnancy, prompt
diagnosis and discussion regarding management options should take
place. Although management options include surgical and medical, it
may be reasonable to consider expectant management for select cases
while weighing risks. In such cases, close monitoring of symptoms and
serial ultrasound examinations should be standard.
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